Blue light eliminates community-acquired methicillin-resistant Staphylococcus aureus in infected mouse skin abrasions

Tianhong Dai, Asheesh Gupta, Ying Ying Huang, Margaret E. Sherwood, Clinton K. Murray, Mark S. Vrahas, Tammy L Kielian, Michael R. Hamblin

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Background and objective: Bacterial skin and soft tissue infections (SSTI) affect millions of individuals annually in the United States. Treatment of SSTI has been significantly complicated by the increasing emergence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) strains. The objective of this study was to demonstrate the efficacy of blue light (415±10 nm) therapy for eliminating CA-MRSA infections in skin abrasions of mice. Methods: The susceptibilities of a CA-MRSA strain (USA300LAC) and human keratinocytes (HaCaT) to blue light inactivation were compared by in vitro culture studies. A mouse model of skin abrasion infection was developed using bioluminescent USA300LAC::lux. Blue light was delivered to the infected mouse skin abrasions at 30 min (acute) and 24 h (established) after the bacterial inoculation. Bioluminescence imaging was used to monitor in real time the extent of infection in mice. Results: USA300LAC was much more susceptible to blue light inactivation than HaCaT cells (p=0.038). Approximately 4.75-log 10 bacterial inactivation was achieved after 170 J/cm2 blue light had been delivered, but only 0.29 log10 loss of viability in HaCaT cells was observed. Transmission electron microscopy imaging of USA300LAC cells exposed to blue light exhibited disruption of the cytoplasmic content, disruption of cell walls, and cell debris. In vivo studies showed that blue light rapidly reduced the bacterial burden in both acute and established CA-MRSA infections. More than 2-log10 reduction of bacterial luminescence in the mouse skin abrasions was achieved when 41.4 (day 0) and 108 J/cm2 (day 1) blue light had been delivered. Bacterial regrowth was observed in the mouse wounds at 24 h after the blue light therapy. Conclusions: There exists a therapeutic window of blue light for bacterial infections where bacteria are selectively inactivated by blue light while host tissue cells are preserved. Blue light therapy has the potential to rapidly reduce the bacterial load in SSTI.

Original languageEnglish (US)
Pages (from-to)531-538
Number of pages8
JournalPhotomedicine and Laser Surgery
Volume31
Issue number11
DOIs
StatePublished - Nov 1 2013

Fingerprint

Methicillin-Resistant Staphylococcus aureus
Abrasion
Skin
Light
Soft Tissue Infections
Phototherapy
Tissue
Infection
Bacterial Load
Bioluminescence
Imaging techniques
Luminescence
Transmission Electron Microscopy
Keratinocytes
Bacterial Infections
Cell Wall
Debris
Bacteria
Cells
Transmission electron microscopy

ASJC Scopus subject areas

  • Biomedical Engineering
  • Radiology Nuclear Medicine and imaging

Cite this

Dai, T., Gupta, A., Huang, Y. Y., Sherwood, M. E., Murray, C. K., Vrahas, M. S., ... Hamblin, M. R. (2013). Blue light eliminates community-acquired methicillin-resistant Staphylococcus aureus in infected mouse skin abrasions. Photomedicine and Laser Surgery, 31(11), 531-538. https://doi.org/10.1089/pho.2012.3365

Blue light eliminates community-acquired methicillin-resistant Staphylococcus aureus in infected mouse skin abrasions. / Dai, Tianhong; Gupta, Asheesh; Huang, Ying Ying; Sherwood, Margaret E.; Murray, Clinton K.; Vrahas, Mark S.; Kielian, Tammy L; Hamblin, Michael R.

In: Photomedicine and Laser Surgery, Vol. 31, No. 11, 01.11.2013, p. 531-538.

Research output: Contribution to journalArticle

Dai, Tianhong ; Gupta, Asheesh ; Huang, Ying Ying ; Sherwood, Margaret E. ; Murray, Clinton K. ; Vrahas, Mark S. ; Kielian, Tammy L ; Hamblin, Michael R. / Blue light eliminates community-acquired methicillin-resistant Staphylococcus aureus in infected mouse skin abrasions. In: Photomedicine and Laser Surgery. 2013 ; Vol. 31, No. 11. pp. 531-538.
@article{30417f6234e44f12a2c3088d44745534,
title = "Blue light eliminates community-acquired methicillin-resistant Staphylococcus aureus in infected mouse skin abrasions",
abstract = "Background and objective: Bacterial skin and soft tissue infections (SSTI) affect millions of individuals annually in the United States. Treatment of SSTI has been significantly complicated by the increasing emergence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) strains. The objective of this study was to demonstrate the efficacy of blue light (415±10 nm) therapy for eliminating CA-MRSA infections in skin abrasions of mice. Methods: The susceptibilities of a CA-MRSA strain (USA300LAC) and human keratinocytes (HaCaT) to blue light inactivation were compared by in vitro culture studies. A mouse model of skin abrasion infection was developed using bioluminescent USA300LAC::lux. Blue light was delivered to the infected mouse skin abrasions at 30 min (acute) and 24 h (established) after the bacterial inoculation. Bioluminescence imaging was used to monitor in real time the extent of infection in mice. Results: USA300LAC was much more susceptible to blue light inactivation than HaCaT cells (p=0.038). Approximately 4.75-log 10 bacterial inactivation was achieved after 170 J/cm2 blue light had been delivered, but only 0.29 log10 loss of viability in HaCaT cells was observed. Transmission electron microscopy imaging of USA300LAC cells exposed to blue light exhibited disruption of the cytoplasmic content, disruption of cell walls, and cell debris. In vivo studies showed that blue light rapidly reduced the bacterial burden in both acute and established CA-MRSA infections. More than 2-log10 reduction of bacterial luminescence in the mouse skin abrasions was achieved when 41.4 (day 0) and 108 J/cm2 (day 1) blue light had been delivered. Bacterial regrowth was observed in the mouse wounds at 24 h after the blue light therapy. Conclusions: There exists a therapeutic window of blue light for bacterial infections where bacteria are selectively inactivated by blue light while host tissue cells are preserved. Blue light therapy has the potential to rapidly reduce the bacterial load in SSTI.",
author = "Tianhong Dai and Asheesh Gupta and Huang, {Ying Ying} and Sherwood, {Margaret E.} and Murray, {Clinton K.} and Vrahas, {Mark S.} and Kielian, {Tammy L} and Hamblin, {Michael R.}",
year = "2013",
month = "11",
day = "1",
doi = "10.1089/pho.2012.3365",
language = "English (US)",
volume = "31",
pages = "531--538",
journal = "Photomedicine and Laser Surgery",
issn = "1549-5418",
publisher = "Mary Ann Liebert Inc.",
number = "11",

}

TY - JOUR

T1 - Blue light eliminates community-acquired methicillin-resistant Staphylococcus aureus in infected mouse skin abrasions

AU - Dai, Tianhong

AU - Gupta, Asheesh

AU - Huang, Ying Ying

AU - Sherwood, Margaret E.

AU - Murray, Clinton K.

AU - Vrahas, Mark S.

AU - Kielian, Tammy L

AU - Hamblin, Michael R.

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Background and objective: Bacterial skin and soft tissue infections (SSTI) affect millions of individuals annually in the United States. Treatment of SSTI has been significantly complicated by the increasing emergence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) strains. The objective of this study was to demonstrate the efficacy of blue light (415±10 nm) therapy for eliminating CA-MRSA infections in skin abrasions of mice. Methods: The susceptibilities of a CA-MRSA strain (USA300LAC) and human keratinocytes (HaCaT) to blue light inactivation were compared by in vitro culture studies. A mouse model of skin abrasion infection was developed using bioluminescent USA300LAC::lux. Blue light was delivered to the infected mouse skin abrasions at 30 min (acute) and 24 h (established) after the bacterial inoculation. Bioluminescence imaging was used to monitor in real time the extent of infection in mice. Results: USA300LAC was much more susceptible to blue light inactivation than HaCaT cells (p=0.038). Approximately 4.75-log 10 bacterial inactivation was achieved after 170 J/cm2 blue light had been delivered, but only 0.29 log10 loss of viability in HaCaT cells was observed. Transmission electron microscopy imaging of USA300LAC cells exposed to blue light exhibited disruption of the cytoplasmic content, disruption of cell walls, and cell debris. In vivo studies showed that blue light rapidly reduced the bacterial burden in both acute and established CA-MRSA infections. More than 2-log10 reduction of bacterial luminescence in the mouse skin abrasions was achieved when 41.4 (day 0) and 108 J/cm2 (day 1) blue light had been delivered. Bacterial regrowth was observed in the mouse wounds at 24 h after the blue light therapy. Conclusions: There exists a therapeutic window of blue light for bacterial infections where bacteria are selectively inactivated by blue light while host tissue cells are preserved. Blue light therapy has the potential to rapidly reduce the bacterial load in SSTI.

AB - Background and objective: Bacterial skin and soft tissue infections (SSTI) affect millions of individuals annually in the United States. Treatment of SSTI has been significantly complicated by the increasing emergence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) strains. The objective of this study was to demonstrate the efficacy of blue light (415±10 nm) therapy for eliminating CA-MRSA infections in skin abrasions of mice. Methods: The susceptibilities of a CA-MRSA strain (USA300LAC) and human keratinocytes (HaCaT) to blue light inactivation were compared by in vitro culture studies. A mouse model of skin abrasion infection was developed using bioluminescent USA300LAC::lux. Blue light was delivered to the infected mouse skin abrasions at 30 min (acute) and 24 h (established) after the bacterial inoculation. Bioluminescence imaging was used to monitor in real time the extent of infection in mice. Results: USA300LAC was much more susceptible to blue light inactivation than HaCaT cells (p=0.038). Approximately 4.75-log 10 bacterial inactivation was achieved after 170 J/cm2 blue light had been delivered, but only 0.29 log10 loss of viability in HaCaT cells was observed. Transmission electron microscopy imaging of USA300LAC cells exposed to blue light exhibited disruption of the cytoplasmic content, disruption of cell walls, and cell debris. In vivo studies showed that blue light rapidly reduced the bacterial burden in both acute and established CA-MRSA infections. More than 2-log10 reduction of bacterial luminescence in the mouse skin abrasions was achieved when 41.4 (day 0) and 108 J/cm2 (day 1) blue light had been delivered. Bacterial regrowth was observed in the mouse wounds at 24 h after the blue light therapy. Conclusions: There exists a therapeutic window of blue light for bacterial infections where bacteria are selectively inactivated by blue light while host tissue cells are preserved. Blue light therapy has the potential to rapidly reduce the bacterial load in SSTI.

UR - http://www.scopus.com/inward/record.url?scp=84887432260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887432260&partnerID=8YFLogxK

U2 - 10.1089/pho.2012.3365

DO - 10.1089/pho.2012.3365

M3 - Article

C2 - 23406384

AN - SCOPUS:84887432260

VL - 31

SP - 531

EP - 538

JO - Photomedicine and Laser Surgery

JF - Photomedicine and Laser Surgery

SN - 1549-5418

IS - 11

ER -